Genoray Balance Sheet Health
Financial Health criteria checks 5/6
Genoray has a total shareholder equity of ₩93.0B and total debt of ₩19.4B, which brings its debt-to-equity ratio to 20.8%. Its total assets and total liabilities are ₩133.1B and ₩40.1B respectively. Genoray's EBIT is ₩10.8B making its interest coverage ratio 56.2. It has cash and short-term investments of ₩15.1B.
Key information
20.8%
Debt to equity ratio
₩19.35b
Debt
| Interest coverage ratio | 56.2x |
| Cash | ₩15.14b |
| Equity | ₩93.01b |
| Total liabilities | ₩40.07b |
| Total assets | ₩133.08b |
Recent financial health updates
Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?
Mar 01
We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt
Nov 30Recent updates
Genoray's (KOSDAQ:122310) Soft Earnings Are Actually Better Than They Appear
Nov 21Why Genoray's (KOSDAQ:122310) Shaky Earnings Are Just The Beginning Of Its Problems
Mar 28Does Genoray Co., Ltd. (KOSDAQ:122310) Have A Place In Your Dividend Portfolio?
Apr 12Does Genoray (KOSDAQ:122310) Have A Healthy Balance Sheet?
Mar 01We Like Genoray's (KOSDAQ:122310) Returns And Here's How They're Trending
Feb 11
Is Genoray Co., Ltd.'s (KOSDAQ:122310) Recent Performance Tethered To Its Attractive Financial Prospects?
Jan 27Is Genoray Co., Ltd. (KOSDAQ:122310) A Smart Choice For Dividend Investors?
Jan 12Genoray Co., Ltd. (KOSDAQ:122310) Looks Interesting, And It's About To Pay A Dividend
Dec 24A Look At The Fair Value Of Genoray Co., Ltd. (KOSDAQ:122310)
Dec 15We Think Genoray (KOSDAQ:122310) Can Stay On Top Of Its Debt
Nov 30Financial Position Analysis
Short Term Liabilities: A122310's short term assets (₩74.7B) exceed its short term liabilities (₩32.4B).
Long Term Liabilities: A122310's short term assets (₩74.7B) exceed its long term liabilities (₩7.6B).
Debt to Equity History and Analysis
Debt Level: A122310's net debt to equity ratio (4.5%) is considered satisfactory.
Reducing Debt: A122310's debt to equity ratio has increased from 16.8% to 20.8% over the past 5 years.
Debt Coverage: A122310's debt is well covered by operating cash flow (37%).
Interest Coverage: A122310's interest payments on its debt are well covered by EBIT (56.2x coverage).